nodes	percent_of_prediction	percent_of_DWPC	metapath
Escitalopram—CYP2C19—Cholecalciferol—osteoporosis	0.0519	0.129	CbGbCtD
Escitalopram—CYP3A4—Calcitriol—osteoporosis	0.0487	0.121	CbGbCtD
Escitalopram—CYP3A4—Estropipate—osteoporosis	0.0487	0.121	CbGbCtD
Escitalopram—CYP2C19—Estradiol—osteoporosis	0.0418	0.104	CbGbCtD
Escitalopram—CYP2D6—Cholecalciferol—osteoporosis	0.0394	0.0982	CbGbCtD
Escitalopram—CYP3A4—Ergocalciferol—osteoporosis	0.0389	0.0969	CbGbCtD
Escitalopram—CYP3A4—Raloxifene—osteoporosis	0.0325	0.0809	CbGbCtD
Escitalopram—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0314	0.0781	CbGbCtD
Escitalopram—CYP3A4—Cholecalciferol—osteoporosis	0.0251	0.0624	CbGbCtD
Escitalopram—CYP3A4—Conjugated Estrogens—osteoporosis	0.023	0.0573	CbGbCtD
Escitalopram—CYP3A4—Estradiol—osteoporosis	0.0202	0.0503	CbGbCtD
Escitalopram—Pruritus—Alendronate—osteoporosis	0.00014	0.000245	CcSEcCtD
Escitalopram—Dyspepsia—Risedronate—osteoporosis	0.000139	0.000244	CcSEcCtD
Escitalopram—Eye disorder—Estradiol—osteoporosis	0.000139	0.000244	CcSEcCtD
Escitalopram—Tinnitus—Estradiol—osteoporosis	0.000139	0.000244	CcSEcCtD
Escitalopram—Constipation—Ethinyl Estradiol—osteoporosis	0.000139	0.000243	CcSEcCtD
Escitalopram—Confusional state—Zoledronate—osteoporosis	0.000139	0.000243	CcSEcCtD
Escitalopram—Hypersensitivity—Calcitriol—osteoporosis	0.000138	0.000243	CcSEcCtD
Escitalopram—Cardiac disorder—Estradiol—osteoporosis	0.000138	0.000243	CcSEcCtD
Escitalopram—Flushing—Estradiol—osteoporosis	0.000138	0.000243	CcSEcCtD
Escitalopram—Chest pain—Conjugated Estrogens—osteoporosis	0.000138	0.000242	CcSEcCtD
Escitalopram—Arthralgia—Conjugated Estrogens—osteoporosis	0.000138	0.000242	CcSEcCtD
Escitalopram—Myalgia—Conjugated Estrogens—osteoporosis	0.000138	0.000242	CcSEcCtD
Escitalopram—Asthenia—Ibandronate—osteoporosis	0.000138	0.000242	CcSEcCtD
Escitalopram—Anxiety—Conjugated Estrogens—osteoporosis	0.000138	0.000241	CcSEcCtD
Escitalopram—Nausea—Etidronic acid—osteoporosis	0.000137	0.000241	CcSEcCtD
Escitalopram—Anaphylactic shock—Zoledronate—osteoporosis	0.000137	0.000241	CcSEcCtD
Escitalopram—Oedema—Zoledronate—osteoporosis	0.000137	0.000241	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000137	0.00024	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000137	0.00024	CcSEcCtD
Escitalopram—Diarrhoea—Estropipate—osteoporosis	0.000137	0.00024	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Risedronate—osteoporosis	0.000137	0.00024	CcSEcCtD
Escitalopram—Infection—Zoledronate—osteoporosis	0.000137	0.000239	CcSEcCtD
Escitalopram—Fatigue—Risedronate—osteoporosis	0.000136	0.000239	CcSEcCtD
Escitalopram—Insomnia—Pamidronate—osteoporosis	0.000136	0.000239	CcSEcCtD
Escitalopram—Pruritus—Ibandronate—osteoporosis	0.000136	0.000238	CcSEcCtD
Escitalopram—Constipation—Risedronate—osteoporosis	0.000135	0.000237	CcSEcCtD
Escitalopram—Pain—Risedronate—osteoporosis	0.000135	0.000237	CcSEcCtD
Escitalopram—Angiopathy—Estradiol—osteoporosis	0.000135	0.000237	CcSEcCtD
Escitalopram—Shock—Zoledronate—osteoporosis	0.000135	0.000237	CcSEcCtD
Escitalopram—Paraesthesia—Pamidronate—osteoporosis	0.000135	0.000237	CcSEcCtD
Escitalopram—Diarrhoea—Alendronate—osteoporosis	0.000135	0.000237	CcSEcCtD
Escitalopram—Asthenia—Calcitriol—osteoporosis	0.000135	0.000237	CcSEcCtD
Escitalopram—Nervous system disorder—Zoledronate—osteoporosis	0.000135	0.000236	CcSEcCtD
Escitalopram—Immune system disorder—Estradiol—osteoporosis	0.000135	0.000236	CcSEcCtD
Escitalopram—Thrombocytopenia—Zoledronate—osteoporosis	0.000135	0.000236	CcSEcCtD
Escitalopram—Mediastinal disorder—Estradiol—osteoporosis	0.000134	0.000236	CcSEcCtD
Escitalopram—Dyspnoea—Pamidronate—osteoporosis	0.000134	0.000235	CcSEcCtD
Escitalopram—Tachycardia—Zoledronate—osteoporosis	0.000134	0.000235	CcSEcCtD
Escitalopram—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000134	0.000235	CcSEcCtD
Escitalopram—Chills—Estradiol—osteoporosis	0.000134	0.000235	CcSEcCtD
Escitalopram—Somnolence—Pamidronate—osteoporosis	0.000134	0.000235	CcSEcCtD
Escitalopram—Skin disorder—Zoledronate—osteoporosis	0.000133	0.000234	CcSEcCtD
Escitalopram—Pruritus—Calcitriol—osteoporosis	0.000133	0.000233	CcSEcCtD
Escitalopram—Hyperhidrosis—Zoledronate—osteoporosis	0.000133	0.000233	CcSEcCtD
Escitalopram—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000133	0.000233	CcSEcCtD
Escitalopram—Diarrhoea—Raloxifene—osteoporosis	0.000133	0.000233	CcSEcCtD
Escitalopram—Dyspepsia—Pamidronate—osteoporosis	0.000132	0.000232	CcSEcCtD
Escitalopram—Dizziness—Estropipate—osteoporosis	0.000132	0.000232	CcSEcCtD
Escitalopram—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000132	0.000232	CcSEcCtD
Escitalopram—Oedema—Conjugated Estrogens—osteoporosis	0.000132	0.000232	CcSEcCtD
Escitalopram—Alopecia—Estradiol—osteoporosis	0.000132	0.000231	CcSEcCtD
Escitalopram—Infection—Conjugated Estrogens—osteoporosis	0.000131	0.000231	CcSEcCtD
Escitalopram—Diarrhoea—Ibandronate—osteoporosis	0.000131	0.00023	CcSEcCtD
Escitalopram—Anorexia—Zoledronate—osteoporosis	0.000131	0.00023	CcSEcCtD
Escitalopram—Decreased appetite—Pamidronate—osteoporosis	0.000131	0.000229	CcSEcCtD
Escitalopram—Mental disorder—Estradiol—osteoporosis	0.000131	0.000229	CcSEcCtD
Escitalopram—Dizziness—Alendronate—osteoporosis	0.00013	0.000229	CcSEcCtD
Escitalopram—Shock—Conjugated Estrogens—osteoporosis	0.00013	0.000228	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00013	0.000228	CcSEcCtD
Escitalopram—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00013	0.000228	CcSEcCtD
Escitalopram—Erythema—Estradiol—osteoporosis	0.00013	0.000228	CcSEcCtD
Escitalopram—Malnutrition—Estradiol—osteoporosis	0.00013	0.000228	CcSEcCtD
Escitalopram—Fatigue—Pamidronate—osteoporosis	0.00013	0.000227	CcSEcCtD
Escitalopram—Gastrointestinal pain—Risedronate—osteoporosis	0.000129	0.000227	CcSEcCtD
Escitalopram—Tachycardia—Conjugated Estrogens—osteoporosis	0.000129	0.000226	CcSEcCtD
Escitalopram—Urticaria—Ethinyl Estradiol—osteoporosis	0.000129	0.000226	CcSEcCtD
Escitalopram—Constipation—Pamidronate—osteoporosis	0.000129	0.000226	CcSEcCtD
Escitalopram—Pain—Pamidronate—osteoporosis	0.000129	0.000226	CcSEcCtD
Escitalopram—Diarrhoea—Calcitriol—osteoporosis	0.000129	0.000226	CcSEcCtD
Escitalopram—Skin disorder—Conjugated Estrogens—osteoporosis	0.000129	0.000225	CcSEcCtD
Escitalopram—Hypotension—Zoledronate—osteoporosis	0.000128	0.000225	CcSEcCtD
Escitalopram—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000128	0.000225	CcSEcCtD
Escitalopram—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000128	0.000225	CcSEcCtD
Escitalopram—Dizziness—Raloxifene—osteoporosis	0.000128	0.000225	CcSEcCtD
Escitalopram—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000128	0.000224	CcSEcCtD
Escitalopram—Flatulence—Estradiol—osteoporosis	0.000128	0.000224	CcSEcCtD
Escitalopram—Tension—Estradiol—osteoporosis	0.000127	0.000223	CcSEcCtD
Escitalopram—Vomiting—Estropipate—osteoporosis	0.000127	0.000223	CcSEcCtD
Escitalopram—Dysgeusia—Estradiol—osteoporosis	0.000127	0.000223	CcSEcCtD
Escitalopram—Dizziness—Ibandronate—osteoporosis	0.000127	0.000223	CcSEcCtD
Escitalopram—Rash—Estropipate—osteoporosis	0.000126	0.000221	CcSEcCtD
Escitalopram—Dermatitis—Estropipate—osteoporosis	0.000126	0.000221	CcSEcCtD
Escitalopram—Anorexia—Conjugated Estrogens—osteoporosis	0.000126	0.000221	CcSEcCtD
Escitalopram—Nervousness—Estradiol—osteoporosis	0.000126	0.000221	CcSEcCtD
Escitalopram—Urticaria—Risedronate—osteoporosis	0.000126	0.00022	CcSEcCtD
Escitalopram—Back pain—Estradiol—osteoporosis	0.000126	0.00022	CcSEcCtD
Escitalopram—Headache—Estropipate—osteoporosis	0.000125	0.00022	CcSEcCtD
Escitalopram—Vomiting—Alendronate—osteoporosis	0.000125	0.00022	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000125	0.00022	CcSEcCtD
Escitalopram—Abdominal pain—Risedronate—osteoporosis	0.000125	0.000219	CcSEcCtD
Escitalopram—Body temperature increased—Risedronate—osteoporosis	0.000125	0.000219	CcSEcCtD
Escitalopram—Muscle spasms—Estradiol—osteoporosis	0.000125	0.000219	CcSEcCtD
Escitalopram—Rash—Alendronate—osteoporosis	0.000124	0.000218	CcSEcCtD
Escitalopram—Insomnia—Zoledronate—osteoporosis	0.000124	0.000218	CcSEcCtD
Escitalopram—Dermatitis—Alendronate—osteoporosis	0.000124	0.000218	CcSEcCtD
Escitalopram—Feeling abnormal—Pamidronate—osteoporosis	0.000124	0.000217	CcSEcCtD
Escitalopram—Hypotension—Conjugated Estrogens—osteoporosis	0.000124	0.000217	CcSEcCtD
Escitalopram—Headache—Alendronate—osteoporosis	0.000124	0.000217	CcSEcCtD
Escitalopram—Paraesthesia—Zoledronate—osteoporosis	0.000123	0.000216	CcSEcCtD
Escitalopram—Vomiting—Raloxifene—osteoporosis	0.000123	0.000216	CcSEcCtD
Escitalopram—Gastrointestinal pain—Pamidronate—osteoporosis	0.000123	0.000216	CcSEcCtD
Escitalopram—Dyspnoea—Zoledronate—osteoporosis	0.000123	0.000215	CcSEcCtD
Escitalopram—Rash—Raloxifene—osteoporosis	0.000122	0.000214	CcSEcCtD
Escitalopram—Dermatitis—Raloxifene—osteoporosis	0.000122	0.000214	CcSEcCtD
Escitalopram—Somnolence—Zoledronate—osteoporosis	0.000122	0.000214	CcSEcCtD
Escitalopram—Vomiting—Ibandronate—osteoporosis	0.000122	0.000214	CcSEcCtD
Escitalopram—Tremor—Estradiol—osteoporosis	0.000122	0.000213	CcSEcCtD
Escitalopram—Headache—Raloxifene—osteoporosis	0.000122	0.000213	CcSEcCtD
Escitalopram—Rash—Ibandronate—osteoporosis	0.000121	0.000212	CcSEcCtD
Escitalopram—Dermatitis—Ibandronate—osteoporosis	0.000121	0.000212	CcSEcCtD
Escitalopram—Dyspepsia—Zoledronate—osteoporosis	0.000121	0.000212	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000121	0.000211	CcSEcCtD
Escitalopram—Ill-defined disorder—Estradiol—osteoporosis	0.00012	0.000211	CcSEcCtD
Escitalopram—Headache—Ibandronate—osteoporosis	0.00012	0.000211	CcSEcCtD
Escitalopram—Insomnia—Conjugated Estrogens—osteoporosis	0.00012	0.00021	CcSEcCtD
Escitalopram—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00012	0.00021	CcSEcCtD
Escitalopram—Vomiting—Calcitriol—osteoporosis	0.00012	0.00021	CcSEcCtD
Escitalopram—Decreased appetite—Zoledronate—osteoporosis	0.000119	0.000209	CcSEcCtD
Escitalopram—Agitation—Estradiol—osteoporosis	0.000119	0.000209	CcSEcCtD
Escitalopram—Nausea—Estropipate—osteoporosis	0.000119	0.000209	CcSEcCtD
Escitalopram—Abdominal pain—Pamidronate—osteoporosis	0.000119	0.000209	CcSEcCtD
Escitalopram—Body temperature increased—Pamidronate—osteoporosis	0.000119	0.000209	CcSEcCtD
Escitalopram—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000119	0.000208	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000119	0.000208	CcSEcCtD
Escitalopram—Angioedema—Estradiol—osteoporosis	0.000119	0.000208	CcSEcCtD
Escitalopram—Rash—Calcitriol—osteoporosis	0.000119	0.000208	CcSEcCtD
Escitalopram—Fatigue—Zoledronate—osteoporosis	0.000118	0.000208	CcSEcCtD
Escitalopram—Dermatitis—Calcitriol—osteoporosis	0.000118	0.000208	CcSEcCtD
Escitalopram—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000118	0.000207	CcSEcCtD
Escitalopram—Headache—Calcitriol—osteoporosis	0.000118	0.000207	CcSEcCtD
Escitalopram—Somnolence—Conjugated Estrogens—osteoporosis	0.000118	0.000206	CcSEcCtD
Escitalopram—Pain—Zoledronate—osteoporosis	0.000118	0.000206	CcSEcCtD
Escitalopram—Constipation—Zoledronate—osteoporosis	0.000118	0.000206	CcSEcCtD
Escitalopram—Nausea—Alendronate—osteoporosis	0.000117	0.000205	CcSEcCtD
Escitalopram—Malaise—Estradiol—osteoporosis	0.000117	0.000205	CcSEcCtD
Escitalopram—Hypersensitivity—Risedronate—osteoporosis	0.000117	0.000204	CcSEcCtD
Escitalopram—Vertigo—Estradiol—osteoporosis	0.000117	0.000204	CcSEcCtD
Escitalopram—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000116	0.000204	CcSEcCtD
Escitalopram—Asthenia—Ethinyl Estradiol—osteoporosis	0.000116	0.000204	CcSEcCtD
Escitalopram—Syncope—Estradiol—osteoporosis	0.000116	0.000204	CcSEcCtD
Escitalopram—Nausea—Raloxifene—osteoporosis	0.000115	0.000202	CcSEcCtD
Escitalopram—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000115	0.000202	CcSEcCtD
Escitalopram—Pruritus—Ethinyl Estradiol—osteoporosis	0.000115	0.000201	CcSEcCtD
Escitalopram—Palpitations—Estradiol—osteoporosis	0.000115	0.000201	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000114	0.0002	CcSEcCtD
Escitalopram—Fatigue—Conjugated Estrogens—osteoporosis	0.000114	0.0002	CcSEcCtD
Escitalopram—Nausea—Ibandronate—osteoporosis	0.000114	0.0002	CcSEcCtD
Escitalopram—Loss of consciousness—Estradiol—osteoporosis	0.000114	0.0002	CcSEcCtD
Escitalopram—Asthenia—Risedronate—osteoporosis	0.000114	0.000199	CcSEcCtD
Escitalopram—Feeling abnormal—Zoledronate—osteoporosis	0.000113	0.000199	CcSEcCtD
Escitalopram—Cough—Estradiol—osteoporosis	0.000113	0.000199	CcSEcCtD
Escitalopram—Pain—Conjugated Estrogens—osteoporosis	0.000113	0.000198	CcSEcCtD
Escitalopram—Constipation—Conjugated Estrogens—osteoporosis	0.000113	0.000198	CcSEcCtD
Escitalopram—Gastrointestinal pain—Zoledronate—osteoporosis	0.000112	0.000197	CcSEcCtD
Escitalopram—Hypertension—Estradiol—osteoporosis	0.000112	0.000196	CcSEcCtD
Escitalopram—Pruritus—Risedronate—osteoporosis	0.000112	0.000196	CcSEcCtD
Escitalopram—Nausea—Calcitriol—osteoporosis	0.000112	0.000196	CcSEcCtD
Escitalopram—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000111	0.000195	CcSEcCtD
Escitalopram—Hypersensitivity—Pamidronate—osteoporosis	0.000111	0.000194	CcSEcCtD
Escitalopram—Myalgia—Estradiol—osteoporosis	0.00011	0.000194	CcSEcCtD
Escitalopram—Chest pain—Estradiol—osteoporosis	0.00011	0.000194	CcSEcCtD
Escitalopram—Arthralgia—Estradiol—osteoporosis	0.00011	0.000194	CcSEcCtD
Escitalopram—Anxiety—Estradiol—osteoporosis	0.00011	0.000193	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.00011	0.000192	CcSEcCtD
Escitalopram—Urticaria—Zoledronate—osteoporosis	0.000109	0.000191	CcSEcCtD
Escitalopram—Discomfort—Estradiol—osteoporosis	0.000109	0.000191	CcSEcCtD
Escitalopram—Abdominal pain—Zoledronate—osteoporosis	0.000109	0.00019	CcSEcCtD
Escitalopram—Body temperature increased—Zoledronate—osteoporosis	0.000109	0.00019	CcSEcCtD
Escitalopram—Diarrhoea—Risedronate—osteoporosis	0.000108	0.00019	CcSEcCtD
Escitalopram—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000108	0.00019	CcSEcCtD
Escitalopram—Dry mouth—Estradiol—osteoporosis	0.000108	0.000189	CcSEcCtD
Escitalopram—Asthenia—Pamidronate—osteoporosis	0.000108	0.000189	CcSEcCtD
Escitalopram—Dizziness—Ethinyl Estradiol—osteoporosis	0.000107	0.000188	CcSEcCtD
Escitalopram—Confusional state—Estradiol—osteoporosis	0.000107	0.000187	CcSEcCtD
Escitalopram—Pruritus—Pamidronate—osteoporosis	0.000106	0.000187	CcSEcCtD
Escitalopram—Oedema—Estradiol—osteoporosis	0.000106	0.000186	CcSEcCtD
Escitalopram—Anaphylactic shock—Estradiol—osteoporosis	0.000106	0.000186	CcSEcCtD
Escitalopram—Infection—Estradiol—osteoporosis	0.000105	0.000184	CcSEcCtD
Escitalopram—Urticaria—Conjugated Estrogens—osteoporosis	0.000105	0.000184	CcSEcCtD
Escitalopram—Dizziness—Risedronate—osteoporosis	0.000105	0.000184	CcSEcCtD
Escitalopram—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000105	0.000183	CcSEcCtD
Escitalopram—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000105	0.000183	CcSEcCtD
Escitalopram—Shock—Estradiol—osteoporosis	0.000104	0.000183	CcSEcCtD
Escitalopram—Nervous system disorder—Estradiol—osteoporosis	0.000104	0.000182	CcSEcCtD
Escitalopram—Tachycardia—Estradiol—osteoporosis	0.000103	0.000181	CcSEcCtD
Escitalopram—Vomiting—Ethinyl Estradiol—osteoporosis	0.000103	0.000181	CcSEcCtD
Escitalopram—Diarrhoea—Pamidronate—osteoporosis	0.000103	0.000181	CcSEcCtD
Escitalopram—Skin disorder—Estradiol—osteoporosis	0.000103	0.00018	CcSEcCtD
Escitalopram—Hyperhidrosis—Estradiol—osteoporosis	0.000102	0.00018	CcSEcCtD
Escitalopram—Rash—Ethinyl Estradiol—osteoporosis	0.000102	0.000179	CcSEcCtD
Escitalopram—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000102	0.000179	CcSEcCtD
Escitalopram—Headache—Ethinyl Estradiol—osteoporosis	0.000102	0.000178	CcSEcCtD
Escitalopram—Hypersensitivity—Zoledronate—osteoporosis	0.000101	0.000178	CcSEcCtD
Escitalopram—Vomiting—Risedronate—osteoporosis	0.000101	0.000176	CcSEcCtD
Escitalopram—Rash—Risedronate—osteoporosis	9.98e-05	0.000175	CcSEcCtD
Escitalopram—Dermatitis—Risedronate—osteoporosis	9.97e-05	0.000175	CcSEcCtD
Escitalopram—Dizziness—Pamidronate—osteoporosis	9.95e-05	0.000174	CcSEcCtD
Escitalopram—Headache—Risedronate—osteoporosis	9.91e-05	0.000174	CcSEcCtD
Escitalopram—Asthenia—Zoledronate—osteoporosis	9.86e-05	0.000173	CcSEcCtD
Escitalopram—Hypersensitivity—Conjugated Estrogens—osteoporosis	9.75e-05	0.000171	CcSEcCtD
Escitalopram—Pruritus—Zoledronate—osteoporosis	9.72e-05	0.00017	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Estradiol—osteoporosis	9.65e-05	0.000169	CcSEcCtD
Escitalopram—Nausea—Ethinyl Estradiol—osteoporosis	9.64e-05	0.000169	CcSEcCtD
Escitalopram—Insomnia—Estradiol—osteoporosis	9.58e-05	0.000168	CcSEcCtD
Escitalopram—Vomiting—Pamidronate—osteoporosis	9.56e-05	0.000168	CcSEcCtD
Escitalopram—Paraesthesia—Estradiol—osteoporosis	9.51e-05	0.000167	CcSEcCtD
Escitalopram—Asthenia—Conjugated Estrogens—osteoporosis	9.49e-05	0.000166	CcSEcCtD
Escitalopram—Rash—Pamidronate—osteoporosis	9.48e-05	0.000166	CcSEcCtD
Escitalopram—Dermatitis—Pamidronate—osteoporosis	9.48e-05	0.000166	CcSEcCtD
Escitalopram—Dyspnoea—Estradiol—osteoporosis	9.44e-05	0.000166	CcSEcCtD
Escitalopram—Headache—Pamidronate—osteoporosis	9.42e-05	0.000165	CcSEcCtD
Escitalopram—Somnolence—Estradiol—osteoporosis	9.41e-05	0.000165	CcSEcCtD
Escitalopram—Diarrhoea—Zoledronate—osteoporosis	9.4e-05	0.000165	CcSEcCtD
Escitalopram—Nausea—Risedronate—osteoporosis	9.4e-05	0.000165	CcSEcCtD
Escitalopram—Pruritus—Conjugated Estrogens—osteoporosis	9.36e-05	0.000164	CcSEcCtD
Escitalopram—Dyspepsia—Estradiol—osteoporosis	9.32e-05	0.000163	CcSEcCtD
Escitalopram—Decreased appetite—Estradiol—osteoporosis	9.2e-05	0.000161	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Estradiol—osteoporosis	9.14e-05	0.00016	CcSEcCtD
Escitalopram—Fatigue—Estradiol—osteoporosis	9.13e-05	0.00016	CcSEcCtD
Escitalopram—Dizziness—Zoledronate—osteoporosis	9.09e-05	0.000159	CcSEcCtD
Escitalopram—Pain—Estradiol—osteoporosis	9.06e-05	0.000159	CcSEcCtD
Escitalopram—Constipation—Estradiol—osteoporosis	9.06e-05	0.000159	CcSEcCtD
Escitalopram—Diarrhoea—Conjugated Estrogens—osteoporosis	9.05e-05	0.000159	CcSEcCtD
Escitalopram—Nausea—Pamidronate—osteoporosis	8.94e-05	0.000157	CcSEcCtD
Escitalopram—Dizziness—Conjugated Estrogens—osteoporosis	8.75e-05	0.000153	CcSEcCtD
Escitalopram—Vomiting—Zoledronate—osteoporosis	8.74e-05	0.000153	CcSEcCtD
Escitalopram—Feeling abnormal—Estradiol—osteoporosis	8.73e-05	0.000153	CcSEcCtD
Escitalopram—Rash—Zoledronate—osteoporosis	8.66e-05	0.000152	CcSEcCtD
Escitalopram—Gastrointestinal pain—Estradiol—osteoporosis	8.66e-05	0.000152	CcSEcCtD
Escitalopram—Dermatitis—Zoledronate—osteoporosis	8.66e-05	0.000152	CcSEcCtD
Escitalopram—Headache—Zoledronate—osteoporosis	8.61e-05	0.000151	CcSEcCtD
Escitalopram—Vomiting—Conjugated Estrogens—osteoporosis	8.41e-05	0.000148	CcSEcCtD
Escitalopram—Urticaria—Estradiol—osteoporosis	8.41e-05	0.000148	CcSEcCtD
Escitalopram—Abdominal pain—Estradiol—osteoporosis	8.37e-05	0.000147	CcSEcCtD
Escitalopram—Body temperature increased—Estradiol—osteoporosis	8.37e-05	0.000147	CcSEcCtD
Escitalopram—Rash—Conjugated Estrogens—osteoporosis	8.34e-05	0.000146	CcSEcCtD
Escitalopram—Dermatitis—Conjugated Estrogens—osteoporosis	8.33e-05	0.000146	CcSEcCtD
Escitalopram—Headache—Conjugated Estrogens—osteoporosis	8.29e-05	0.000145	CcSEcCtD
Escitalopram—Nausea—Zoledronate—osteoporosis	8.16e-05	0.000143	CcSEcCtD
Escitalopram—Nausea—Conjugated Estrogens—osteoporosis	7.86e-05	0.000138	CcSEcCtD
Escitalopram—Hypersensitivity—Estradiol—osteoporosis	7.8e-05	0.000137	CcSEcCtD
Escitalopram—Asthenia—Estradiol—osteoporosis	7.6e-05	0.000133	CcSEcCtD
Escitalopram—Pruritus—Estradiol—osteoporosis	7.49e-05	0.000131	CcSEcCtD
Escitalopram—Diarrhoea—Estradiol—osteoporosis	7.25e-05	0.000127	CcSEcCtD
Escitalopram—Dizziness—Estradiol—osteoporosis	7e-05	0.000123	CcSEcCtD
Escitalopram—Vomiting—Estradiol—osteoporosis	6.73e-05	0.000118	CcSEcCtD
Escitalopram—Rash—Estradiol—osteoporosis	6.68e-05	0.000117	CcSEcCtD
Escitalopram—Dermatitis—Estradiol—osteoporosis	6.67e-05	0.000117	CcSEcCtD
Escitalopram—Headache—Estradiol—osteoporosis	6.63e-05	0.000116	CcSEcCtD
Escitalopram—Nausea—Estradiol—osteoporosis	6.29e-05	0.00011	CcSEcCtD
Escitalopram—CYP2C19—Metabolism—FDPS—osteoporosis	3.01e-05	0.00106	CbGpPWpGaD
Escitalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	3.01e-05	0.00106	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CNR2—osteoporosis	3e-05	0.00106	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—PTHLH—osteoporosis	3e-05	0.00106	CbGpPWpGaD
Escitalopram—CYP2D6—Biological oxidations—POMC—osteoporosis	2.94e-05	0.00104	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—CALCA—osteoporosis	2.91e-05	0.00103	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—WNT1—osteoporosis	2.87e-05	0.00101	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—WNT1—osteoporosis	2.86e-05	0.00101	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—PTHLH—osteoporosis	2.86e-05	0.00101	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GPD2—osteoporosis	2.86e-05	0.00101	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PGLS—osteoporosis	2.86e-05	0.00101	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—PTHLH—osteoporosis	2.85e-05	0.00101	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—WNT1—osteoporosis	2.82e-05	0.000996	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—PTHLH—osteoporosis	2.81e-05	0.000992	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MGLL—osteoporosis	2.8e-05	0.00099	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MGLL—osteoporosis	2.79e-05	0.000986	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—FDPS—osteoporosis	2.77e-05	0.000979	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PKM—osteoporosis	2.77e-05	0.000979	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MGLL—osteoporosis	2.75e-05	0.000971	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—LRP5—osteoporosis	2.73e-05	0.000966	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—LRP5—osteoporosis	2.73e-05	0.000963	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—POMC—osteoporosis	2.69e-05	0.000951	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—LRP5—osteoporosis	2.68e-05	0.000948	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—CALCA—osteoporosis	2.64e-05	0.000933	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GPD2—osteoporosis	2.63e-05	0.000928	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PGLS—osteoporosis	2.63e-05	0.000928	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—LRP6—osteoporosis	2.62e-05	0.000924	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ATIC—osteoporosis	2.61e-05	0.000923	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PNP—osteoporosis	2.61e-05	0.000923	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—LRP6—osteoporosis	2.61e-05	0.000921	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—PTHLH—osteoporosis	2.6e-05	0.000918	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—PTHLH—osteoporosis	2.59e-05	0.000915	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—LRP6—osteoporosis	2.57e-05	0.000907	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—PTHLH—osteoporosis	2.55e-05	0.000901	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TLN1—osteoporosis	2.55e-05	0.0009	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—CALCA—osteoporosis	2.52e-05	0.00089	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—CALCA—osteoporosis	2.51e-05	0.000887	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—CALCA—osteoporosis	2.47e-05	0.000873	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PNP—osteoporosis	2.4e-05	0.000849	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ATIC—osteoporosis	2.4e-05	0.000849	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—POMC—osteoporosis	2.33e-05	0.000824	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—POMC—osteoporosis	2.33e-05	0.000821	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—POMC—osteoporosis	2.29e-05	0.000808	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CALCA—osteoporosis	2.29e-05	0.000808	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CALCA—osteoporosis	2.28e-05	0.000806	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CALCA—osteoporosis	2.25e-05	0.000793	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—OXCT1—osteoporosis	2.22e-05	0.000785	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CA2—osteoporosis	2.22e-05	0.000785	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TLN1—osteoporosis	2.21e-05	0.00078	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TLN1—osteoporosis	2.2e-05	0.000778	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—P4HB—osteoporosis	2.2e-05	0.000776	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TLN1—osteoporosis	2.17e-05	0.000766	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—MGLL—osteoporosis	2.16e-05	0.000765	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PTH—osteoporosis	2.14e-05	0.000755	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—RAP1A—osteoporosis	2.1e-05	0.000742	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CNR2—osteoporosis	2.08e-05	0.000736	CbGpPWpGaD
Escitalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	2.07e-05	0.000733	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—ADCY5—osteoporosis	2.07e-05	0.000731	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NFATC1—osteoporosis	2.05e-05	0.000724	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—OXCT1—osteoporosis	2.04e-05	0.000722	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CA2—osteoporosis	2.04e-05	0.000722	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.04e-05	0.000721	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—DKK1—osteoporosis	2.03e-05	0.000718	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—MGLL—osteoporosis	1.99e-05	0.000703	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—WNT1—osteoporosis	1.96e-05	0.000692	CbGpPWpGaD
Escitalopram—CYP3A4—Biological oxidations—POMC—osteoporosis	1.92e-05	0.000678	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—FGA—osteoporosis	1.91e-05	0.000673	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—P4HB—osteoporosis	1.9e-05	0.000673	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—P4HB—osteoporosis	1.9e-05	0.000671	CbGpPWpGaD
Escitalopram—CHRM1—Circadian rythm related genes—IL6—osteoporosis	1.89e-05	0.000668	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—ADCY5—osteoporosis	1.88e-05	0.000663	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—P4HB—osteoporosis	1.87e-05	0.00066	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PTH—osteoporosis	1.85e-05	0.000654	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PTH—osteoporosis	1.85e-05	0.000652	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—IDH2—osteoporosis	1.84e-05	0.00065	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—RAP1A—osteoporosis	1.82e-05	0.000643	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PTH—osteoporosis	1.82e-05	0.000642	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—RAP1A—osteoporosis	1.81e-05	0.000641	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—FDPS—osteoporosis	1.81e-05	0.00064	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PKM—osteoporosis	1.81e-05	0.00064	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CNR2—osteoporosis	1.81e-05	0.000638	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CNR2—osteoporosis	1.8e-05	0.000636	CbGpPWpGaD
Escitalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	1.8e-05	0.000635	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—ADCY5—osteoporosis	1.79e-05	0.000633	CbGpPWpGaD
Escitalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	1.79e-05	0.000633	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—RAP1A—osteoporosis	1.79e-05	0.000631	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—ADCY5—osteoporosis	1.79e-05	0.000631	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NFATC1—osteoporosis	1.78e-05	0.000627	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CNR2—osteoporosis	1.77e-05	0.000626	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—BMP2—osteoporosis	1.77e-05	0.000626	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PTHLH—osteoporosis	1.77e-05	0.000626	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NFATC1—osteoporosis	1.77e-05	0.000625	CbGpPWpGaD
Escitalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	1.76e-05	0.000623	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—DKK1—osteoporosis	1.76e-05	0.000622	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—ADCY5—osteoporosis	1.76e-05	0.000621	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—DKK1—osteoporosis	1.76e-05	0.00062	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NFATC1—osteoporosis	1.74e-05	0.000616	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—FGB—osteoporosis	1.73e-05	0.000612	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CYP27A1—osteoporosis	1.73e-05	0.000611	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—DKK1—osteoporosis	1.73e-05	0.000611	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GPD2—osteoporosis	1.72e-05	0.000607	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PGLS—osteoporosis	1.72e-05	0.000607	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—WNT1—osteoporosis	1.7e-05	0.0006	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—IDH2—osteoporosis	1.69e-05	0.000598	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—WNT1—osteoporosis	1.69e-05	0.000598	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ACP5—osteoporosis	1.68e-05	0.000595	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PSMA2—osteoporosis	1.67e-05	0.000591	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PSMA5—osteoporosis	1.67e-05	0.000591	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—WNT1—osteoporosis	1.67e-05	0.000588	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.66e-05	0.000587	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—FGA—osteoporosis	1.65e-05	0.000583	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—FGA—osteoporosis	1.65e-05	0.000581	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—ADCY5—osteoporosis	1.63e-05	0.000575	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—ADCY5—osteoporosis	1.62e-05	0.000573	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—FGA—osteoporosis	1.62e-05	0.000572	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—ADCY5—osteoporosis	1.6e-05	0.000564	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.59e-05	0.000562	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PNP—osteoporosis	1.57e-05	0.000555	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ATIC—osteoporosis	1.57e-05	0.000555	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—TPI1—osteoporosis	1.56e-05	0.000553	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CALCA—osteoporosis	1.56e-05	0.000551	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ACP5—osteoporosis	1.55e-05	0.000547	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—BMP2—osteoporosis	1.54e-05	0.000542	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PTHLH—osteoporosis	1.54e-05	0.000542	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PTHLH—osteoporosis	1.53e-05	0.000541	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—BMP2—osteoporosis	1.53e-05	0.000541	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—POMC—osteoporosis	1.52e-05	0.000537	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PTHLH—osteoporosis	1.51e-05	0.000532	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—BMP2—osteoporosis	1.51e-05	0.000532	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—FGB—osteoporosis	1.5e-05	0.000531	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—FGB—osteoporosis	1.5e-05	0.000529	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—FGB—osteoporosis	1.47e-05	0.000521	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—P4HB—osteoporosis	1.47e-05	0.00052	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PSMA2—osteoporosis	1.45e-05	0.000512	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PSMA5—osteoporosis	1.45e-05	0.000512	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PSMA5—osteoporosis	1.45e-05	0.000511	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PSMA2—osteoporosis	1.45e-05	0.000511	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GAPDH—osteoporosis	1.44e-05	0.00051	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—TPI1—osteoporosis	1.44e-05	0.000508	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PSMA2—osteoporosis	1.42e-05	0.000503	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PSMA5—osteoporosis	1.42e-05	0.000503	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—KL—osteoporosis	1.42e-05	0.0005	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—RAP1A—osteoporosis	1.41e-05	0.000497	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—POMC—osteoporosis	1.38e-05	0.000488	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—P4HB—osteoporosis	1.35e-05	0.000478	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CALCA—osteoporosis	1.35e-05	0.000477	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—IL6R—osteoporosis	1.35e-05	0.000476	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CALCA—osteoporosis	1.35e-05	0.000476	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CA2—osteoporosis	1.34e-05	0.000472	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—OXCT1—osteoporosis	1.34e-05	0.000472	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GAPDH—osteoporosis	1.33e-05	0.000469	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CALCA—osteoporosis	1.33e-05	0.000468	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—POMC—osteoporosis	1.32e-05	0.000466	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—POMC—osteoporosis	1.31e-05	0.000464	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—MGLL—osteoporosis	1.3e-05	0.00046	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—RAP1A—osteoporosis	1.29e-05	0.000457	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—POMC—osteoporosis	1.29e-05	0.000457	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—KL—osteoporosis	1.23e-05	0.000433	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.23e-05	0.000433	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—KL—osteoporosis	1.22e-05	0.000432	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—KL—osteoporosis	1.2e-05	0.000425	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—POMC—osteoporosis	1.2e-05	0.000423	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—POMC—osteoporosis	1.19e-05	0.000421	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—POMC—osteoporosis	1.17e-05	0.000415	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—IL6R—osteoporosis	1.17e-05	0.000412	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—IL6R—osteoporosis	1.16e-05	0.000411	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—IL6R—osteoporosis	1.15e-05	0.000405	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ENO1—osteoporosis	1.14e-05	0.000402	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PSMA2—osteoporosis	1.12e-05	0.000396	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PSMA5—osteoporosis	1.12e-05	0.000396	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—ADCY5—osteoporosis	1.11e-05	0.000392	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—IDH2—osteoporosis	1.11e-05	0.000391	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—SPP1—osteoporosis	1.07e-05	0.000379	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ENO1—osteoporosis	1.05e-05	0.000369	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.04e-05	0.000368	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PSMA2—osteoporosis	1.03e-05	0.000364	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PSMA5—osteoporosis	1.03e-05	0.000364	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ACP5—osteoporosis	1.01e-05	0.000358	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IRS2—osteoporosis	9.71e-06	0.000343	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—ADCY5—osteoporosis	9.61e-06	0.00034	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—ADCY5—osteoporosis	9.58e-06	0.000338	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—LEP—osteoporosis	9.5e-06	0.000336	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	9.43e-06	0.000333	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—TPI1—osteoporosis	9.41e-06	0.000332	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—SPP1—osteoporosis	9.3e-06	0.000329	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—SPP1—osteoporosis	9.27e-06	0.000327	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—SPP1—osteoporosis	9.13e-06	0.000322	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CYP19A1—osteoporosis	9.09e-06	0.000321	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—ESR1—osteoporosis	9.07e-06	0.00032	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—P4HB—osteoporosis	8.85e-06	0.000313	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GAPDH—osteoporosis	8.68e-06	0.000307	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IRS1—osteoporosis	8.47e-06	0.000299	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—RAP1A—osteoporosis	8.46e-06	0.000299	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IRS2—osteoporosis	8.41e-06	0.000297	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IRS2—osteoporosis	8.38e-06	0.000296	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CYP19A1—osteoporosis	8.36e-06	0.000295	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IRS2—osteoporosis	8.25e-06	0.000292	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—LEP—osteoporosis	8.23e-06	0.000291	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—LEP—osteoporosis	8.2e-06	0.00029	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—POMC—osteoporosis	8.16e-06	0.000288	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—LEP—osteoporosis	8.08e-06	0.000285	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IL6R—osteoporosis	7.96e-06	0.000281	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—ESR1—osteoporosis	7.86e-06	0.000278	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IGF1—osteoporosis	7.85e-06	0.000277	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—ESR1—osteoporosis	7.83e-06	0.000277	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—ESR1—osteoporosis	7.71e-06	0.000272	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ADCY5—osteoporosis	7.43e-06	0.000262	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GPX1—osteoporosis	7.4e-06	0.000261	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IRS1—osteoporosis	7.34e-06	0.000259	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IRS1—osteoporosis	7.32e-06	0.000259	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IRS1—osteoporosis	7.21e-06	0.000255	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—POMC—osteoporosis	7.07e-06	0.00025	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—POMC—osteoporosis	7.05e-06	0.000249	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—POMC—osteoporosis	6.94e-06	0.000245	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IL6R—osteoporosis	6.9e-06	0.000244	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IL6R—osteoporosis	6.88e-06	0.000243	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ENO1—osteoporosis	6.84e-06	0.000241	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ADCY5—osteoporosis	6.83e-06	0.000241	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—MTHFR—osteoporosis	6.83e-06	0.000241	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GPX1—osteoporosis	6.81e-06	0.00024	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IGF1—osteoporosis	6.8e-06	0.00024	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IGF1—osteoporosis	6.78e-06	0.000239	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IL6R—osteoporosis	6.77e-06	0.000239	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PSMA2—osteoporosis	6.74e-06	0.000238	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PSMA5—osteoporosis	6.74e-06	0.000238	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IGF1—osteoporosis	6.67e-06	0.000236	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—MTHFR—osteoporosis	6.28e-06	0.000222	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—IL6—osteoporosis	6e-06	0.000212	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP19A1—osteoporosis	5.47e-06	0.000193	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—POMC—osteoporosis	5.46e-06	0.000193	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—IL6—osteoporosis	5.2e-06	0.000184	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—IL6—osteoporosis	5.18e-06	0.000183	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—IL6—osteoporosis	5.1e-06	0.00018	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—POMC—osteoporosis	5.02e-06	0.000177	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MYC—osteoporosis	4.72e-06	0.000167	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TGFB1—osteoporosis	4.71e-06	0.000166	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ADCY5—osteoporosis	4.47e-06	0.000158	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GPX1—osteoporosis	4.45e-06	0.000157	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—MTHFR—osteoporosis	4.11e-06	0.000145	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MYC—osteoporosis	4.09e-06	0.000144	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TGFB1—osteoporosis	4.08e-06	0.000144	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MYC—osteoporosis	4.07e-06	0.000144	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TGFB1—osteoporosis	4.06e-06	0.000144	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MYC—osteoporosis	4.01e-06	0.000142	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	4e-06	0.000141	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IL6—osteoporosis	3.55e-06	0.000125	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—POMC—osteoporosis	3.28e-06	0.000116	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IL6—osteoporosis	3.07e-06	0.000109	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IL6—osteoporosis	3.06e-06	0.000108	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IL6—osteoporosis	3.02e-06	0.000107	CbGpPWpGaD
